ReviewBiomedicines2023

The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials.

Paweł Moćko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.